Enoksimon

Enoksimon
Klinički podaci
Drugs.comMonografija
Način primeneOralno
Identifikatori
CAS broj77671-31-9 Зелена квачицаДа
ATC kodC01CE03 (WHO)
PubChemCID 53708
DrugBankDB04880 Зелена квачицаДа
ChemSpider48492 Зелена квачицаДа
ChEMBLCHEMBL249856 Зелена квачицаДа

Enoksimon je organsko jedinjenje, koje sadrži 12 atoma ugljenika i ima molekulsku masu od 248,301 Da.[1][2][3][4][5][6]

Osobine

Osobina Vrednost
Broj akceptora vodonika 3
Broj donora vodonika 2
Broj rotacionih veza 3
Particioni koeficijent[7] (ALogP) 1,3
Rastvorljivost[8] (logS, log(mol/L)) -3,0
Polarna površina[9] (PSA, Å2) 83,5

Reference

  1. ^ Sandroni C, Cavallaro F, Caricato A, Scapigliati A, Fenici P, Antonelli M: Enoximone in cardiac arrest caused by propranolol: two case reports. Sandroni, C.; Cavallaro, F.; Caricato, A.; Scapigliati, A.; Fenici, P.; Antonelli, M. (2006 Jul). „Enoximone in cardiac arrest caused by propranolol: Two case reports”. Acta Anaesthesiol Scand. 50 (6): 759—61. PMID 16987374. doi:10.1111/j.1399-6576.2006.01026.x.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  2. ^ van der Maaten JM, de Vries AJ, Rietman GW, Gallandat Huet RC, De Hert SG: Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis. J Cardiothorac Vasc Anesth. Van Der Maaten, J. M.; De Vries, A. J.; Rietman, G. W.; Gallandat Huet, R. C.; De Hert, S. G. (2007 Jun). „Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis”. Journal of Cardiothoracic and Vascular Anesthesia. 21 (3): 357—66. PMID 17544886. doi:10.1053/j.jvca.2006.01.006.  Проверите вредност парамет(а)ра за датум: |date= (помоћ). Epub 2006 May 4.
  3. ^ Schauvliege S, Van den Eede A, Duchateau L, Gasthuys F: Cardiovascular effects of enoximone in isoflurane anaesthetized ponies. Vet Anaesth Analg. 2007 Aug 13;. Schauvliege, S.; Van Den Eede, A.; Duchateau, L.; Gasthuys, F. (2007). „Cardiovascular effects of enoximone in isoflurane anaesthetized ponies”. Veterinary Anaesthesia and Analgesia. 34 (6): 416—430. PMID 17696974. doi:10.1111/j.1467-2995.2007.00343.x. 
  4. ^ Boldt J, Suttner S: Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone. Boldt, J.; Suttner, S. (2007 Sep). „Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone”. Expert Opin Pharmacother. 8 (13): 2135—47. PMID 17714066. doi:10.1517/14656566.8.13.2135.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  5. ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  6. ^ Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  7. ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 
  8. ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  9. ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e. 

Literatura

Spoljašnje veze

Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.